JEANNE DAVIS: Open Payments
NPI 1619477171 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,116 in 134 payments from 22 companies in 2025. Trend: 2023 $4,411 · 2024 $5,788 · 2025 $4,116
Food & beverage: $4,111Education: $5
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 32 | $662 |
| Neurocrine BioSciences, Inc. | 23 | $459 |
| Boston Scientific Corporation | 4 | $337 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $335 |
| Janssen Pharmaceuticals, Inc | 9 | $271 |
| Otsuka America Pharmaceutical, Inc. | 10 | $244 |
| Alkermes, Inc. | 7 | $215 |
| Vanda Pharmaceuticals Inc. | 12 | $210 |
| Teva Pharmaceuticals USA, Inc. | 9 | $182 |
| E.R. Squibb & Sons, L.L.C. | 4 | $175 |
Products named: Auvelity, INGREZZA, WaveWriter Alpha Prime 16, INVEGA SUSTENNA, FANAPT, REXULTI, COBENFY, Rystiggo.
Industry payments across NY — which companies pay providers there.
